Prosecution Insights
Last updated: July 17, 2026
Application No. 18/800,214

COMPRESSION DEVICE, KIT, AND METHOD

Final Rejection §101
Filed
Aug 12, 2024
Priority
Sep 11, 2019 — divisional of 11/510,713 +1 more
Examiner
CHANG, OLIVIA C
Art Unit
3775
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Medline Industries L.P.
OA Round
3 (Final)
84%
Grant Probability
Favorable
4-5
OA Rounds
11m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allowance Rate
616 granted / 731 resolved
+14.3% vs TC avg
Moderate +14% lift
Without
With
+13.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
24 currently pending
Career history
757
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
58.7%
+18.7% vs TC avg
§102
27.6%
-12.4% vs TC avg
§112
11.9%
-28.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 731 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment This office action is in response to the amendment filed June 24, 2026. As directed by the amendment, claim 16 has been amended and claims 27-34 have been added. However, claims 27-34 do not read on the elected species because they include features drawn to non-elected species. Therefore, claims 27-34 are withdrawn. As such, claims 16-26 remain under consideration in the instant application. Double Patenting A rejection based on double patenting of the “same invention” type finds its support in the language of 35 U.S.C. 101 which states that “whoever invents or discovers any new and useful process... may obtain a patent therefor...” (Emphasis added). Thus, the term “same invention,” in this context, means an invention drawn to identical subject matter. See Miller v. Eagle Mfg. Co., 151 U.S. 186 (1894); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Ockert, 245 F.2d 467, 114 USPQ 330 (CCPA 1957). A statutory type (35 U.S.C. 101) double patenting rejection can be overcome by canceling or amending the claims that are directed to the same invention so they are no longer coextensive in scope. The filing of a terminal disclaimer cannot overcome a double patenting rejection based upon 35 U.S.C. 101. Claims 16-26 is/are rejected under 35 U.S.C. 101 as claiming the same invention as that of claims 16-26 of prior U.S. Patent No. 12,102,362. This is a statutory double patenting rejection. Response to Arguments In response to Applicant's argument that both rejections are now moot, Examiner respectfully disagrees. The double patenting rejection has not been addressed and remains valid. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to OLIVIA C CHANG whose telephone number is (571) 270-5017. The examiner can normally be reached Monday-Friday, 7:30AM-5:00PM. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, KEVIN TRUONG, at (571) 272-4705. The fax phone number for the organization where this application or proceeding is assigned is 571 -273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /OLIVIA C CHANG/Primary Examiner, Art Unit 3775
Read full office action

Prosecution Timeline

Aug 12, 2024
Application Filed
Mar 25, 2026
Non-Final Rejection mailed — §101
Apr 01, 2026
Response Filed
May 06, 2026
Non-Final Rejection mailed — §101
Jun 24, 2026
Response Filed
Jul 07, 2026
Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12661163
BONE PLATE WITH FORM-FITTING VARIABLE-ANGLE LOCKING HOLE
5y 1m to grant Granted Jun 23, 2026
Patent 12653588
EXPANDABLE IMPLANT, IMPLANT SYSTEM, KIT OF PARTS FOR ASSEMBLING AN EXPANDABLE IMPLANT, AND METHOD OF PLACING AN IMPLANT IN A BONE
3y 5m to grant Granted Jun 16, 2026
Patent 12653590
DETACHABLE BONE FIXATION DEVICE AND RELATED METHODS
3y 0m to grant Granted Jun 16, 2026
Patent 12653587
MAXILLARY EXPANDER AND PROTRACTION DEVICE
2y 6m to grant Granted Jun 16, 2026
Patent 12636054
BONE ANCHOR
3y 3m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5
Expected OA Rounds
84%
Grant Probability
98%
With Interview (+13.5%)
2y 10m (~11m remaining)
Median Time to Grant
High
PTA Risk
Based on 731 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month